Hansoh heralds China’s move from ‘follower’ to ‘frontrunner’ in biopharma race

Hansoh Pharmaceutical has given a bullish assessment of China’s innovative pharma sector, arguing that the industry is “fully transitioning from the ‘follower’ to the ‘frontrunner’ phase.”